Synopsis
Synopsis
0
API Suppliers
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
API
0
FDF
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. 28956-89-0
2. Bcv386qguz
3. 11beta,17,21-trihydroxypregn-4-ene-3,20-dione 17-benzoate
4. (8s,9s,10r,11s,13s,14s,17r)-11-hydroxy-17-(2-hydroxyacetyl)-10,13-dimethyl-3-oxo-2,3,6,7,8,9,10,11,12,13,14,15,16,17-tetradecahydro-1h-cyclopenta[a]phenanthren-17-yl Benzoate
5. Einecs 249-328-8
6. Unii-bcv386qguz
7. Hydrocortisone 17-benzoate
8. Benzodrocortisone [inn]
9. Gtpl9731
10. Schembl14935737
11. Dtxsid10951574
12. Bdbm323671
13. Zinc31391536
14. Compound 1 [wo2013071010]
15. Us10188667, Example 00012
16. Us10188667, Example 00028
17. [(8s,9s,10r,11s,13s,14s,17r)-11-hydroxy-17-(2-hydroxyacetyl)-10,13-dimethyl-3-oxo-2,6,7,8,9,11,12,14,15,16-decahydro-1h-cyclopenta[a]phenanthren-17-yl] Benzoate
18. 17-(benzoyloxy)-11beta,21-dihydroxypregn-4-ene-3,20-dione
19. Pregn-4-ene-3,20-dione, 17-(benzoyloxy)-11,21-dihydroxy-, (11.beta.)-
20. [(8s,9s,10r,11s,13s,14s,17r)-11-hydroxy-17-(2-hydroxy-acetyl)-10,13-dimethyl-3-oxo-2,6,7,8,9,11,12,14,15,16-decahydro-1h-cyclopenta[a]phenanthren-17-yl] Benzoate
21. Cortisol, 17-benzoate(11.beta.)-17-(benzoyloxy)-11,21-dihydroxypregn-4-ene-3,20-dione
| Molecular Weight | 466.6 g/mol |
|---|---|
| Molecular Formula | C28H34O6 |
| XLogP3 | 4 |
| Hydrogen Bond Donor Count | 2 |
| Hydrogen Bond Acceptor Count | 6 |
| Rotatable Bond Count | 5 |
| Exact Mass | 466.23553880 g/mol |
| Monoisotopic Mass | 466.23553880 g/mol |
| Topological Polar Surface Area | 101 Ų |
| Heavy Atom Count | 34 |
| Formal Charge | 0 |
| Complexity | 903 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 7 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 1 |
ABOUT THIS PAGE
A Benzodrocortisone manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Benzodrocortisone, including repackagers and relabelers. The FDA regulates Benzodrocortisone manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Benzodrocortisone API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A Benzodrocortisone supplier is an individual or a company that provides Benzodrocortisone active pharmaceutical ingredient (API) or Benzodrocortisone finished formulations upon request. The Benzodrocortisone suppliers may include Benzodrocortisone API manufacturers, exporters, distributors and traders.
Benzodrocortisone Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Benzodrocortisone GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Benzodrocortisone GMP manufacturer or Benzodrocortisone GMP API supplier for your needs.
A Benzodrocortisone CoA (Certificate of Analysis) is a formal document that attests to Benzodrocortisone's compliance with Benzodrocortisone specifications and serves as a tool for batch-level quality control.
Benzodrocortisone CoA mostly includes findings from lab analyses of a specific batch. For each Benzodrocortisone CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Benzodrocortisone may be tested according to a variety of international standards, such as European Pharmacopoeia (Benzodrocortisone EP), Benzodrocortisone JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Benzodrocortisone USP).
LOOKING FOR A SUPPLIER?
